Scotia Capital Inc. Astrazeneca PLC Transaction History
Scotia Capital Inc.
- $17.8 Billion
- Q3 2024
A detailed history of Scotia Capital Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Scotia Capital Inc. holds 413,542 shares of AZN stock, worth $27.1 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
413,542
Previous 373,755
10.65%
Holding current value
$27.1 Million
Previous $29.1 Million
10.55%
% of portfolio
0.18%
Previous 0.17%
Shares
26 transactions
Others Institutions Holding AZN
# of Institutions
1,359Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.13 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.76 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.44 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.42 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.27 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $203B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...